A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Currently, 5.4 million Americans suffer from AD, and these numbers are expected to increase up to 16 million by 2050. Despite tremendous research efforts, we still do not have drugs or agents that can delay, or prevent AD and its progression, and we still do not have early detectable biomarkers for AD. Multiple cellular changes have been implicated in AD, including synaptic damage, mitochondrial damage, production and accumulation of Aβ and phosphorylated tau, inflammatory response, deficits in neurotransmitters, deregulation of the cell cycle, and hormonal imbalance. Research into AD has revealed that miRNAs are involved in each of these cellular changes and interfere with gene regulation and translation. Recent discoveries in molecular biology have also revealed that microRNAs play a major role in post-translational regulation of gene expression. The purpose of this article is to review research that has assessed neuroprotective and neurodegenerative characteristics of microRNAs in brain samples from AD transgenic mouse models and patients with AD.

[1]  Monika J. Madej,et al.  Identification of small non-coding RNAs from mitochondria and chloroplasts , 2006, Nucleic acids research.

[2]  Peter T. Nelson,et al.  Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter , 2011, Acta Neuropathologica.

[3]  E. Junn,et al.  MicroRNAs in neurodegenerative diseases and their therapeutic potential. , 2012, Pharmacology & therapeutics.

[4]  Eva Benito,et al.  MicroRNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease , 2014, The EMBO journal.

[5]  M. Maral Mouradian,et al.  MicroRNAs in Parkinson's disease , 2012, Neurobiology of Disease.

[6]  Harsh Dweep,et al.  A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy , 2012, PloS one.

[7]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[8]  W. Lukiw,et al.  Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line. , 2013, Journal of inorganic biochemistry.

[9]  D. Weil,et al.  Mitochondria Associate with P-bodies and Modulate MicroRNA-mediated RNA Interference* , 2011, The Journal of Biological Chemistry.

[10]  L. Bocchio-Chiavetto,et al.  Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders , 2014, Front. Cell. Neurosci..

[11]  Thomas Braun,et al.  Analysis of newly established EST databases reveals similarities between heart regeneration in newt and fish , 2010, BMC Genomics.

[12]  S. Hébert,et al.  In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs , 2011, Journal of neurochemistry.

[13]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[14]  E. Mufson,et al.  Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment , 2015, Front. Neurosci..

[15]  G. Siasos,et al.  The emerging role of microRNA in stroke. , 2013, Current topics in medicinal chemistry.

[16]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[17]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[18]  Na Li,et al.  Comprehensive survey of human brain microRNA by deep sequencing , 2010, BMC Genomics.

[19]  D. Galimberti,et al.  Circulating miRNAs as potential biomarkers in Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[20]  C. Steer,et al.  MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis , 2009, RNA biology.

[21]  J. Simpkins,et al.  Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity , 2016, Brain Research.

[22]  S. McWeeney,et al.  Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models , 2006, Neurobiology of Aging.

[23]  Ramesh Kandimalla,et al.  Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. , 2016, Biochimica et biophysica acta.

[24]  X. Gidrol,et al.  Pre-microRNA and Mature microRNA in Human Mitochondria , 2011, PloS one.

[25]  J. Dartigues,et al.  Mutation in the 3’untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy , 2015, European Journal of Human Genetics.

[26]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[27]  Thomas Tuschl,et al.  Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. , 2015, The Journal of clinical investigation.

[28]  N. Saini,et al.  Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 , 2014, Molecular Cancer.

[29]  D. Holtzman,et al.  microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain , 2015, The Journal of Neuroscience.

[30]  Walter J. Lukiw,et al.  Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain , 2012, Molecular Neurobiology.

[31]  Benjamin S. Kong,et al.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling , 2014, Neurobiology of Aging.

[32]  Joe D. Hoffman,et al.  y'=-y, of of of , 2018, Numerical Methods for Engineers and Scientists.

[33]  Juhyun Song,et al.  miR-155 is involved in Alzheimer’s disease by regulating T lymphocyte function , 2015, Front. Aging Neurosci..

[34]  Wei Chen,et al.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. , 2012, Toxicology letters.

[35]  Israel Hernandez,et al.  The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule , 2009, The Journal of Neuroscience.

[36]  Christine S. Siegismund,et al.  MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease , 2015, PloS one.

[37]  B. Long,et al.  miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor. , 2013, Free radical biology & medicine.

[38]  Konstantin Khrapko,et al.  A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.

[39]  Qihong Huang,et al.  MicroRNAs can regulate human APP levels , 2008, Molecular Neurodegeneration.

[40]  Bing Liu,et al.  Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease , 2016, Aging.

[41]  Luc Buée,et al.  Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. , 2010, Human molecular genetics.

[42]  Murray J. Cairns,et al.  MicroRNA dysregulation in schizophrenia , 2012, Neurobiology of Disease.

[43]  J. Kocerha,et al.  Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys , 2013, BMC Neuroscience.

[44]  Anna M. Krichevsky,et al.  MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons , 2013, The Journal of Neuroscience.

[45]  S. Pan,et al.  MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. , 2015, Molecular medicine reports.

[46]  Lianfeng Zhang,et al.  miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor , 2010, Brain Research.

[47]  B. Ray,et al.  MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects* , 2013, The Journal of Biological Chemistry.

[48]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[49]  M. Wolfe,et al.  Alternative polyadenylation and miR‐34 family members regulate tau expression , 2013, Journal of neurochemistry.

[50]  Jincheng Li,et al.  Correction: miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway , 2010, PLoS Genetics.

[51]  G. Calin,et al.  Cell-to-cell miRNA transfer: from body homeostasis to therapy. , 2012, Pharmacology & therapeutics.

[52]  P. Reddy,et al.  Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. , 2011, Biochimica et biophysica acta.

[53]  Yan Zhang,et al.  MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer’s disease , 2014, Neuroscience Bulletin.

[54]  D. Bennett,et al.  Change in risk of Alzheimer disease over time , 2010, Neurology.

[55]  Ya-ping Tang,et al.  Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.

[56]  Xiaozhong Peng,et al.  MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice , 2012, Neurobiology of Aging.

[57]  A. Pisco,et al.  MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior Axis , 2011, Developmental cell.

[58]  Gunter Meister,et al.  Argonaute proteins: mediators of RNA silencing. , 2007, Molecular cell.

[59]  F. Nicolás,et al.  MicroRNAs in human diseases. , 2010, Recent patents on DNA & gene sequences.

[60]  W. Lukiw,et al.  microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.

[61]  R. Malenka,et al.  An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration , 2012, Nature Neuroscience.

[62]  F. LaFerla,et al.  Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.

[63]  Elisa Izaurralde,et al.  Deadenylation is a widespread effect of miRNA regulation. , 2008, RNA.

[64]  X. Chen,et al.  Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions , 2010, Cell Research.

[65]  P. Huang,et al.  Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression , 2010, Oncogene.

[66]  Vishwanath T. Anekonda,et al.  Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. , 2012, Biochimica et biophysica acta.

[67]  D. Walsh,et al.  De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. , 2013, Human molecular genetics.

[68]  E. Olson,et al.  MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. , 2013, The Journal of clinical investigation.

[69]  Juan Nunez-Iglesias,et al.  Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation , 2010, PloS one.

[70]  Qunfeng Lin,et al.  MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein. , 2015, European review for medical and pharmacological sciences.

[71]  Yuhai Zhao,et al.  Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. , 2009, Journal of inorganic biochemistry.

[72]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[73]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[74]  Fani Sousa,et al.  Recombinant pre-miR-29b for Alzheimer´s disease therapeutics , 2016, Scientific Reports.

[75]  X. Gu,et al.  microRNA expression profiles in human colorectal cancers with brain metastases. , 2012, Oncology letters.

[76]  J. Satoh,et al.  Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3 , 2010, Neuropathology and applied neurobiology.

[77]  Pei-Chang Wang,et al.  MicroRNA-193 b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193 b is a biomarker of Alzheimer ' s disease , 2014 .

[78]  D. Lahiri,et al.  Current drug targets for modulating Alzheimer's amyloid precursor protein: role of specific micro-RNA species. , 2011, Current medicinal chemistry.

[79]  Jürgen Götz,et al.  Decoding the non-coding RNAs in Alzheimer’s disease , 2012, Cellular and Molecular Life Sciences.

[80]  R. J. Kelleher,et al.  The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.

[81]  Yenarae Lee,et al.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons , 2014, Molecular Neurobiology.

[82]  J. Roh,et al.  miR‐206 regulates brain‐derived neurotrophic factor in Alzheimer disease model , 2012, Annals of neurology.

[83]  Supriyo De,et al.  Age-related changes in microRNA levels in serum , 2013, Aging.

[84]  T. Preiss,et al.  Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.

[85]  L. Harries.  MicroRNAs as Mediators of the Ageing Process , 2014, Genes.

[86]  P. Reddy,et al.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease , 2011, Brain Research.

[87]  C. Caltagirone,et al.  NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection? , 2013, Molecular and Cellular Biochemistry.

[88]  Joseph Loscalzo,et al.  MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. , 2009, Cell metabolism.

[89]  S. Hébert,et al.  Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function , 2011, Molecular Neurodegeneration.

[90]  P. Riva,et al.  The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis , 2017, Molecular Neurobiology.

[91]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[92]  Yanrui Li,et al.  miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.

[93]  Dawei Xu,et al.  MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1. , 2016, Experimental and therapeutic medicine.

[94]  U. Bhadra,et al.  A Complex Genome-MicroRNA Interplay in Human Mitochondria , 2015, BioMed research international.

[95]  J. Koenderink.  Q… , 2014, Les noms officiels des communes de Wallonie, de Bruxelles-Capitale et de la communaute germanophone.

[96]  J. Cui,et al.  Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models , 2011, Neuroscience Letters.

[97]  P. Reddy,et al.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? , 2016, Biochimica et biophysica acta.

[98]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[99]  P. Reddy,et al.  Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. , 2010, Journal of Alzheimer's disease : JAD.

[100]  F. Eisenhaber,et al.  RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells , 2010, Journal of Cell Science.

[101]  O. Franco,et al.  Genome-wide identification of microRNA-related variants associated with risk of Alzheimer’s disease , 2016, Scientific Reports.

[102]  Jürgen Götz,et al.  Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β , 2011, Journal of Molecular Neuroscience.

[103]  Peng Liu,et al.  miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation , 2009, Brain Research Bulletin.

[104]  B. Bao,et al.  Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer , 2011, PloS one.

[105]  C. Spradley,et al.  Circulating miRNAs as Potential Marker for Pulmonary Hypertension , 2013, PloS one.

[106]  Rui Han,et al.  MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling , 2011, Neuroreport.

[107]  Borivoj Vojnovic,et al.  MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU , 2010, PloS one.

[108]  Wolfgang Wurst,et al.  Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10 , 2012, BMC Medical Genetics.

[109]  C. Barbato,et al.  MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons* , 2010, The Journal of Biological Chemistry.

[110]  S. Hébert,et al.  MicroRNAs and Alzheimer's Disease Mouse Models: Current Insights and Future Research Avenues , 2011, International journal of Alzheimer's disease.

[111]  Michael T. McManus,et al.  Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus , 2008, The Journal of Neuroscience.